KERYX BIOPHARMACEUTICALS INC (KERX) Class Action Lawsuit (August 2016)

Closed

19-1964 • August 26, 2016

Class Period Start

May 8, 2013

Class Period End

August 1, 2016

PSLRA Deadline

October 3, 2016

Case Allegations

10b5

Statutes of Repose

May 8, 2016

Country

United States

Court

Federal Court

Docket History

Apr 30, 2019

Motion for Class Certification (opens in a new tab)

The plaintiffs have asked the court to approve the lawsuit to proceed as a class action on behalf of a group of investors. The judge will decide whether the case meets the requirements for class certification and which investors and claims may be included.

Apr 1, 2019

Voluntary Dismissal (opens in a new tab)

The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.

Jul 19, 2018

Motion to Dismiss Denied (opens in a new tab)

The court has denied the defendants' request to dismiss the lawsuit. The case can now move forward to the next stage of litigation.

Oct 2, 2017

Motion to Dismiss (opens in a new tab)

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Feb 27, 2017

First Amended Complaint (opens in a new tab)

A new complaint has been filed on behalf of certain investors in KERYX BIOPHARMACEUTICALS INC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Dec 28, 2016

Appointment of Lead Plaintiff (opens in a new tab)

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Aug 26, 2016

First Filed Complaint (opens in a new tab)

A securities fraud class action complaint has been filed on behalf of certain investors in KERYX BIOPHARMACEUTICALS INC.